Ischemia and reperfusion injury in renal transplantation: hemodynamic and immunological paradigms

• Main Author: Requião-Moura,Lúcio Roberto
• Publication Date: 2015
• Other Authors: Durão Junior,Marcelino de Souza, Matos,Ana Cristina Carvalho de, Pacheco-Silva,Alvaro
• Format: Article
• Language: eng
• Source: Einstein (São Paulo)
• Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000100023
• topic: Reperfusion injury; Ischemia; Delayed graft function; Graft rejection; Perfusion/utilization

Ischemia and reperfusion injury is an inevitable event in renal transplantation. The most important consequences are delayed graft function, longer length of stay, higher hospital costs, high risk of acute rejection, and negative impact of long-term follow-up. Currently, many factors are involved in their pathophysiology and could be classified into two different paradigms for education purposes: hemodynamic and immune. The hemodynamic paradigm is described as the reduction of oxygen delivery due to blood flow interruption, involving many hormone systems, and oxygen-free radicals produced after reperfusion. The immune paradigm has been recently described and involves immune system cells, especially T cells, with a central role in this injury. According to these concepts, new strategies to prevent ischemia and reperfusion injury have been studied, particularly the more physiological forms of storing the kidney, such as the pump machine and the use of antilymphocyte antibody therapy before reperfusion. Pump machine perfusion reduces delayed graft function prevalence and length of stay at hospital, and increases long-term graft survival. The use of antilymphocyte antibody therapy before reperfusion, such as Thymoglobulin™, can reduce the prevalence of delayed graft function and chronic graft dysfunction.